Medpace (MEDP) PT Raised to $35.50 at Jefferies; Reiterates Hold
Jefferies raised its price target on Medpace (NASDAQ: MEDP) to $35.50 (from $34.00) while maintaining a Hold rating. Guidance targets ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
